rdf:type |
|
lifeskim:mentions |
umls-concept:C0005767,
umls-concept:C0021753,
umls-concept:C0021756,
umls-concept:C0021760,
umls-concept:C0063710,
umls-concept:C0079189,
umls-concept:C0085295,
umls-concept:C0180499,
umls-concept:C0205164,
umls-concept:C0205373,
umls-concept:C0231491,
umls-concept:C0597357,
umls-concept:C0812246,
umls-concept:C1456820,
umls-concept:C1555794,
umls-concept:C1749467
|
pubmed:issue |
2
|
pubmed:dateCreated |
1999-5-17
|
pubmed:abstractText |
To measure the concentration of the cytokines interleukin-1beta (IL-1beta), interleukin-2 (IL-2), interleukin-6 (IL-6), interleukin-10 (IL-10), and tumour necrosis factor-alpha (TNF-alpha) and the modulators of their function interleukin-1 receptor antagonist (IL-1Ra), interleukin-2 soluble receptor alpha (IL-2 sRalpha), interleukin-6 soluble receptor (IL-6sR) and soluble tumour necrosis factor receptor I (sTNFR-I) in systemic and drained blood for the first six hours after a major orthopaedic operation.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-1,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-10,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukins,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin-1,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin-6,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1102-4151
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
165
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
101-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10192566-Adolescent,
pubmed-meshheading:10192566-Child,
pubmed-meshheading:10192566-Female,
pubmed-meshheading:10192566-Humans,
pubmed-meshheading:10192566-Interleukin-1,
pubmed-meshheading:10192566-Interleukin-10,
pubmed-meshheading:10192566-Interleukin-2,
pubmed-meshheading:10192566-Interleukin-6,
pubmed-meshheading:10192566-Interleukins,
pubmed-meshheading:10192566-Male,
pubmed-meshheading:10192566-Orthopedic Procedures,
pubmed-meshheading:10192566-Receptors, Interleukin,
pubmed-meshheading:10192566-Receptors, Interleukin-1,
pubmed-meshheading:10192566-Receptors, Interleukin-6,
pubmed-meshheading:10192566-Receptors, Tumor Necrosis Factor,
pubmed-meshheading:10192566-Scoliosis,
pubmed-meshheading:10192566-Tumor Necrosis Factor-alpha
|
pubmed:year |
1999
|
pubmed:articleTitle |
The cytokines IL-1beta and IL-1 receptor antagonist, IL-2 and IL-2 soluble receptor-alpha, IL-6 and IL-6 soluble receptor, TNF-alpha and TNF soluble receptor I, and IL10 in drained and systemic blood after major orthopaedic surgery.
|
pubmed:affiliation |
Centre for Orthopaedics, National Hospital, Trondhjemsveien, Oslo, Norway.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|